Working… Menu

A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration (CDER)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02462928
Recruitment Status : Completed
First Posted : June 4, 2015
Last Update Posted : July 24, 2019
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 18, 2018
Actual Study Completion Date : June 19, 2019
Certification/Extension First Submitted : March 25, 2019